Detalhe da pesquisa
1.
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
N Engl J Med
; 378(25): 2386-2398, 2018 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860938
2.
Statistical considerations in clinical trial design with event-free survival as the primary efficacy endpoint.
Pharm Stat
; 20(4): 721-736, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33594827
3.
Ceritinib in ALK-rearranged non-small-cell lung cancer.
N Engl J Med
; 370(13): 1189-97, 2014 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24670165
4.
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia.
J Clin Oncol
; 39(1): 57-65, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119479
5.
TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
N Engl J Med
; 357(25): 2552-61, 2007 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18094376
6.
Association of colonoscopy and death from colorectal cancer.
Ann Intern Med
; 150(1): 1-8, 2009 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-19075198
7.
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.
Blood Adv
; 4(9): 1894-1905, 2020 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380538
8.
Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice.
Gastroenterology
; 135(6): 1899-1906, 1906.e1, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18938166
9.
Phase 1 Single- and Multiple-Ascending-Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG-348, a First-in-Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 8(2): 246-259, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30091852
10.
Pisces did not have increased heart failure: data-driven comparisons of binary proportions between levels of a categorical variable can result in incorrect statistical significance levels.
J Clin Epidemiol
; 61(3): 295-300, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18226754
11.
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study.
J Clin Oncol
; 23(34): 8646-54, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16314626
12.
Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.
J Clin Oncol
; 22(13): 2701-7, 2004 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15226337
13.
Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer.
J Clin Oncol
; 28(17): 2839-46, 2010 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20458040
14.
Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
J Clin Oncol
; 25(25): 3971-7, 2007 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17761982
15.
Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.
Blood
; 110(5): 1607-11, 2007 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17485550
16.
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.
Blood
; 107(11): 4508-13, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16493009
17.
Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias.
Br J Haematol
; 131(2): 185-92, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16197448
18.
Utilization of Ig heavy chain variable, diversity, and joining gene segments in children with B-lineage acute lymphoblastic leukemia: implications for the mechanisms of VDJ recombination and for pathogenesis.
Blood
; 103(12): 4602-9, 2004 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15010366